José L. Güell
Emilio Segovia
Javier Celis Sánchez
Miriam Barbany
Mercè Morral
Paula Verdaguer
According to several publications, Descemet-endothelial keratoplasty (DEK or DMEK) has a faster and better visual recovery than with other keratoplasty techniques with endothelium transplantation such as penetrating (PK) and endothelial lamellar (ELK or DSAEK), with best-corrected visual acuity (BCVA) greater than 0.5 in 95% of the cases 6 months after the intervention1 (Table 1).
DESCEMET-ENDOTHELIAL KERATOPLASTY COMPARED WITH PENETRATING KERATOPLASTY
In comparison with PK, DEK (DMEK) presents a superior final BCVA and the intervention does not induce significant refractive changes2,3. In addition, the risk of rejection associated with DEK is significantly lower, around 1%4. This allows to reduce the use of corticosteroids in the postoperative period or to switch earlier to those with little intraocular penetration. The endothelium is maintained in figures equal to or better than with PK5,6.
DESCEMET-ENDOTHELIAL KERATOPLASTY COMPARED WITH ENDOTHELIAL LAMELLAR KERATOPLASTY
While ELK (DSAEK) includes a lamella of donor's posterior stroma, DEK (DMEK) comprises only Descemet’s membrane and endothelium. Consequently, there is no stromal interface, which would explain the better results of visual acuity and quality than in the former (Table 2)7. The percentage of patients with BCVA greater than or equal to 0.5 is 60%-80% in ELK and 80%-95% in DEK. In addition, it has been observed in the latter BCVA greater than or equal to 1.0 decimal between 25% to 40% of cases, a lower degree of high order corneal aberrations and better optical quality8. While DEK does not induce any refractive changes, it is common to observe an induced hyperopia of 1 to 3 diopters with ELK and even astigmatism in some cases9-11. The risk of immunological rejection also decreases in order and magnitude. As we can see in table 2, the rejection rates after ELK vary between 1% and 18%, while in DEK they are of the order of 1% or less (table 1) (see also chapter 7.5.4).
ELK, on the other hand, is superior to DEK in some factors among which are included: (1) lower learning curve due to easier manipulation of the graft, (2) lower rate of dislocations (ELK between 1% and 35% against DEK between 1% and 60%)12-14, (3) lower incidence of air/gas reinjections and reinterventions. However, it should be noted that in many cases dislocations in DEK do not affect the transparency of the cornea and it is not always necessary to perform any additional maneuvers. The percentages of primary failure of the graft are similar in both techniques, between 1% and 8% (tables 1 and 2)15,16.
On the other hand, variations have been developed in ELK, such as the «ultrathin» (ut-DSAEK), with refractive and visual results comparable to DEK and greater ease in graft manipulation17. There are also hybrid techniques that include a central disc of Descemet-endothelium and a peripheral zone with a portion of posterior stroma, with the objective of maintaining the refractive advantages of DEK together with the easier manipulation of the tissue of ELK.
All these data show that DEK has many advantages compared to the rest of endothelial transplant modalities. It is, however, a relatively recent technique, which is why many of its aspects are in evolution, whether preoperatively – e.g. tissue preparation in the eye bank – intraoperative maneuvers and associated technologies – injectors and other surgical materials, etc. – or postoperative, and should continue to be analyzed until a most refined technique is defined, which produces greater reproducibility, better results and fewer complications.
BIBLIOGRAPHY
1. Price MO, Giebel AW, Fairchild KM, Price FW Jr. Descemet’s membrane endothelial keratoplasty: prospective multicenter study of visual and refractive outcomes and endothelial survival. Ophthalmology. 2009; 116: 2361-2368.
2. Bahar I, Kaiserman I, McAllum P, et al. Comparison of posterior lamellar keratoplasty techniques to penetrating keratoplasty. Ophthalmology. 2008; 115: 1525- 1533.
3. Kosker M, Suri K, Duman F, et al. Long-term outcomes of penetrating keratoplasty and Descemet stripping endothelial keratoplasty for Fuchs endothelial dystrophy: fellow eye comparison. Cornea. 2013; 32: 1083- 1088.
4. Anshu A, Price MO, Price FW Jr. Risk of corneal transplant rejection significantly reduced with Descemet’s membrane endothelial keratoplasty. Ophthalmology. 2012; 119: 536-540.
5. Ang M, Mehta JS, Anshu A, et al. Endothelial cell counts after Descemet’s stripping automated endothelial keratoplasty versus penetrating keratoplasty in Asian eyes. Clin Ophthalmol. 2012; 6: 537-544.
6. Price MO, Gorovoy M, Price FW Jr, et al. Descemet’s stripping automated endothelial keratoplasty: three-year graft and endothelial cell survival compared with penetrating keratoplasty. Ophthalmology. 2013; 120: 246-251.
7. Van Dijk K, Ham L, Tse WH, et al. Near complete visual recovery and refractive stability in modern corneal transplantation: Descemet membrane endothelial keratoplasty (DMEK). Cont Lens Anterior Eye. 2013; 36: 13-21.
8. Van der Meulen IJ, van Riet TC, Lapid-Gortzak R, et al. Correlation of straylight and visual acuity in long-term follow-up of manual Descemet stripping endothelial keratoplasty. Cornea. 2012; 31: 380-386.
9. Koenig SB, Covert DJ, Dupps WJ Jr, Meisler DM. Visual acuity, refractive error, and endothelial cell density six months after Descemet stripping and automated endothelial keratoplasty (DSAEK). Cornea. 2007; 26: 670- 674.
10. Jun B, Kuo AN, Afshari NA, et al. Refractive change after Descemet stripping automated endothelial keratoplasty surgery and its correlation with graft thickness and diameter. Cornea. 2009; 28: 19-23.
11. Weller KK, Unterlauft JD, Geerling G. 1-year results after posterior lamellar keratoplasty with manually dissected donor tissue. Klin Monbl Augenheilkd. 2010; 227: 460-466.
12. Chaurasia S, Vaddavalli PK, Ramappa M, et al. Clinical profile of graft detachment and outcomes of rebubbling after Descemet stripping endothelial keratoplasty. Br J Ophthalmol. 2011; 95: 1509-1512.
13. Villarrubia A, Palacín E, Aránguez C, et al. Complications after endothelial keratoplasty: three years of experience. Arch Soc Esp Oftalmol. 2011; 86: 180-186.
14. Basak SK, Basak S. Complications and management in Descemet’s stripping endothelial keratoplasty: Analysis of consecutive 430 cases. Indian J Ophthalmol. 2014; 62: 209-218.
15. Price MO, Fairchild KM, Price DA, Price FW Jr. Descemet’s stripping endothelial keratoplasty five-year graft survival and endothelial cell loss. Ophthalmology. 2011; 118: 725-729.
16. Moura GS, Oliveira GM, Tognon T, et al. Complications after Descemet’s stripping endothelial keratoplasty. Arq Bras Oftalmol. 2013; 76: 288-291.
17. Busin M, Madi S, Santorum P, et al. Ultrathin Descemet’s stripping automated endothelial keratoplasty with the microkeratome double-pass technique: two-year outcomes. Ophthalmology. 2013; 120: 1186-1194.